Cutler Group LP Inovio Pharmaceuticals, Inc. Call Options Transaction History

Cutler Group LP

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 04, 2022	SELL	$1.44 - $3.98 $1,152 - $3,184	-800 Reduced 53.33%	700 $0
Q1 2022 Apr 14, 2022	SELL	$2.97 - $5.2 $4,455 - $7,800	-1,500 Reduced 50.0%	1,500 $0
Q2 2021 Jul 19, 2021	BUY	$6.23 - $10.03 $1,869 - $3,009	300 Added 11.11%	3,000 $2,000
Q1 2021 Apr 26, 2021	SELL	$8.81 - $16.96 $13,215 - $25,440	-1,500 Reduced 35.71%	2,700 $4,000
Q4 2020 Jan 21, 2021	SELL	$8.5 - $12.85 $193,800 - $292,980	-22,800 Reduced 84.44%	4,200 $4,000
Q3 2020 Oct 27, 2020	SELL	$9.57 - $27.05 $903,408 - $2.55 Million	-94,400 Reduced 77.76%	27,000 $40,000
Q2 2020 Jul 22, 2020	SELL	$7.14 - $31.69 $1.12 Million - $4.96 Million	-156,600 Reduced 56.33%	121,400 $886,000
Q1 2020 May 07, 2020	BUY	$2.98 - $14.09 $828,142 - $3.92 Million	277,900 Added 277900.0%	278,000 $369,000
Q4 2017 Jan 17, 2018	SELL	$4.13 - $6.68 $106,554 - $172,344	-25,800 Reduced 99.61%	100 $0
Q3 2017 Oct 17, 2017	BUY	$5.36 - $6.37 $138,824 - $164,983	25,900	25,900 $6,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $456M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.